Stock ETON ETON PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Eton Pharmaceuticals, Inc.

Equities

ETON

US29772L1089

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
3.58 USD -0.56% Intraday chart for Eton Pharmaceuticals, Inc. -1.10% -18.26%
May. 09 Transcript : Eton Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024
May. 09 Eton Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Evolution of the average Target Price on Eton Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

ac4b4f0356.iY2TKOQRSUr6DxNHW3zv00T7z8I8JAvLJLUOolrQ9cY.1sjnZd1ZJg6UUGcXKhGtmXeTnJ1TYDiJEuNiwziKn5LCyadkg1B_OLM2Kw~73a06e68d094a13878e2b01e5bb7942b

Analyst Recommendations on Eton Pharmaceuticals, Inc.

HC Wainwright Adjusts Eton Pharmaceuticals Price Target to $10 From $9, Maintains Buy Rating MT
HC Wainwright Trims Price Target on Eton Pharmaceuticals to $9 From $10, Maintains Buy Rating MT
HC Wainwright Adjusts Eton Pharmaceuticals' Price Target to $10 From $9, Keeps Buy Rating MT
HC Wainwright Adjusts Eton Pharmaceuticals' Price Target to $9 from $11, Keeps Buy Rating MT
B. Riley Trims Eton Pharmaceuticals' Price Target to $9 from $10 But Notes 'Solid' Growth Prospects Despite Partner Setback, Keeps Buy Rating MT
HC Wainwright Adjusts Eton Pharmaceuticals' Price Target to $11 From $14, Keeps Buy Rating MT
ETON PHARMACEUTICALS : B. Riley Resumes Eton Pharmaceuticals at Buy with $10 PT, Sees Potential in 'Robust' Pipeline Despite Regulatory Challenges, Related Delays MT
ETON PHARMACEUTICALS : B. Riley Lowers Eton Pharmaceuticals' PT to $11 from $13 on Lowered Probability of Success for DS100, Keeps Buy Rating MT
ETON PHARMACEUTICALS : HC Wainwright Adjusts Eton Pharmaceuticals's Price Target to $15 From $20, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.58 USD
Average target price
8 USD
Spread / Average Target
+123.46%
High Price Target
8 USD
Spread / Highest target
+123.46%
Low Price Target
8 USD
Spread / Lowest Target
+123.46%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Eton Pharmaceuticals, Inc.

HC Wainwright
B. Riley

Ratings for Eton Pharmaceuticals, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ETON Stock
  4. Consensus Eton Pharmaceuticals, Inc.